Correction to: Cell Death and Disease https://doi.org/10.1038/s41419-021-03971-7, published online 13 July 2021
The original version of this article, unfortunately, contained a mistake in Figure 2. The correct figure is given below. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ritter, V., Krautter, F., Klein, D. et al. Correction to: Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy. Cell Death Dis 13, 367 (2022). https://doi.org/10.1038/s41419-022-04743-7
Published:
Version of record:
DOI: https://doi.org/10.1038/s41419-022-04743-7
